Clinical trial
Magnetocardiography as a Noninvasive Diagnostic Strategy for Suspected Myocardial Ischemia With No Obstructive Coronary Artery Disease
NCT06212466 is registered in ClinicalTrials.gov with Genetesis Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Magnetocardiography as a Noninvasive Diagnostic Strategy for Suspected Myocardial Ischemia With No Obstructive Coronary Artery Disease
- Lead sponsor
- Genetesis Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 3, 2024
- Completion date
- April 15, 2025
- Enrollment
- 136 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
angina, coronary microvascular disease, ischemic heart disease, myocardial ischemia